Trails Edge Capital Partners, LP: NURIX THERAPEUTICS INC (NRIX): Quarterly 13F Position History
As of Q2 2026, Trails Edge Capital Partners, LP reported 1,573,220 shares of NURIX THERAPEUTICS INC (NRIX), worth $38.2M and representing 6.1% of its 13F equity book. Quarter-over-quarter share count change: 170,000 (-9.8%) . The position first appeared in Q4 2025 and has been disclosed across 3 13F-HR filings in Pactolio's tracked window.
- 1,573,220Shares Held (Latest Filing)
- $38.2MReported Market Value (Latest Filing)
- 6.1%Portfolio Weight (% of 13F Equity Book)
- 170,000Quarter-over-Quarter Share Change
- +$11.1MQuarter-over-Quarter Value Change
- 1,743,220Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 3 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,573,220 | 170,000 | -9.8% | $38.2M | 6.1% | $24.3 |
| Q1 2026 | 1,743,220 | 0 | – | $27.0M | 6.4% | $15.5 |
| Q4 2025 | 1,743,220 | – | – | $33.1M | 8.2% | $19.0 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Trails Edge Capital Partners, LP first disclose a NRIX position in 13F-HR filings?
Trails Edge Capital Partners, LP first reported NURIX THERAPEUTICS INC (NRIX) on its 13F-HR filing for the period ending 2025-12-31 (Q4 2025). The position has appeared on 3 reported quarters within Pactolio's tracked window.
What was Trails Edge Capital Partners, LP's most recent quarter-over-quarter share-count change in NRIX?
Between Q1 2026 and Q2 2026, Trails Edge Capital Partners, LP reduced its NRIX position by 170,000 shares (-9.8%), leaving 1,573,220 shares at a market value of $38.2M.
Does the implied price-per-share represent Trails Edge Capital Partners, LP's cost basis in NRIX?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.